Position in CTNM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,970,433
+$2,228,892 QoQ
Shares Held
669,337
0.0% QoQ
Ownership
1.78%
of shares outstanding
% of Portfolio
1.32%
of 13F equity value
Holder Rank
#16
of 101 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CTNM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HHLR ADVISORS, LTD. holds $365,309,791 across 9 Biotechnology names. CTNM ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LEGN |
Legend Biotech Corp
|
5,984,550 | $172,833,804 | |
| 2 | AVBP |
ArriVent BioPharma, Inc.
|
3,929,117 | $136,497,524 | |
| 3 | ODTX |
Odyssey Therapeutics, Inc.
|
831,656 | $15,560,283 | |
| 4 | NBP |
NovaBridge Biosciences
|
5,980,568 | $11,662,107 | |
| 5 | CTNM |
Contineum Therapeutics, Inc.
This page
|
669,337 | $10,970,433 | |
| 6 | MAZE |
Maze Therapeutics, Inc.
|
366,028 | $10,922,275 | |
| 7 | SGMT |
Sagimet Biosciences Inc.
|
724,800 | $5,602,704 | |
| 8 | GOSS |
Gossamer Bio, Inc.
|
4,974,041 | $820,716 |
All Filings in CTNM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,970,433 | 669,337 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $8,741,541 | 669,337 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $7,650,521 | 669,337 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $7,864,709 | 669,337 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,657,267 | 669,337 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $4,671,972 | 669,337 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $9,805,787 | 669,337 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $12,811,110 | 669,337 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $11,787,024 | 669,337 | Shares | Other | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||